The answer: more power
Here is where the rubber meets the road on the FDA's Food Protection Plan. Note the provision for third party inspectors, the authority to regulate food security and defense measures and the call for expanded recall authority. One industry leader said the new authority may also help spur the FDA to quicker reaction times in a recall scenario. For example, it has apparently not been uncommon for there to be significant delays in the issuance of a news release of a food recall because of the back and forth process between the FDA and company officials about the wording of news releases alerting the public of a recall.
From the FDA Food Protection Plan:
ADDITIONAL PROTECTIONS THAT INVOLVE LEGISLATIVE CHANGES TO FDA'S AUTHORITY
PREVENT Foodborne Contamination
Allow FDA to Require Preventive Controls to Prevent Intentional Adulteration by Terrorists or Criminals at Points of High Vulnerability in the Food Chain
Authorize FDA to Issue Additional Preventive Controls for High-Risk Foods
Require Food Facilities to Renew Their FDA Registrations Every Two Years, and Allow FDA to Modify the Registration Categories
INTERVENE at Critical Points in the Food Supply Chain
Authorize FDA to Accredit Highly Qualified Third Parties for Voluntary Food Inspections
Require New Reinspection Fee From Facilities That Fail to Meet current Good Manufacturing Practices (cGMPs)
Authorize FDA to Require Electronic Import Certificates for Shipments of Designated High-Risk Products
Require New Food and Animal Feed Export Certification Fee to Improve the Ability of U.S. Firms to Export Their Products
Provide Parity Between Domestic and Imported Foods if FDA Inspection Access is Delayed, Limited, or Denied
RESPOND Rapidly to Minimize Harm
Empower FDA to Issue a Mandatory Recall of Food Products When Voluntary Recalls Are Not Effective
Give FDA Enhanced Access to Food Records During Emergencies
Labels: FDA
1 Comments:
Interesting on the "voluntary" third party inspections. I think a proviso that says "only voluntary" should be written. Some third part work could be an asset but if the FDA can show that it can do it at the same or cheaper cost level (per current A86 memo protocol) its personnel should be allowed to do it and charge the fee. Danger here, of course, are administration's "sweetheart" deals.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home